| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.04 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |